Employees Provident Fund Board

Position in MRK — Merck & Co., Inc.

CIK 1600177 Shah Alam, N8

Back to MRK Full portfolio

Position in MRK

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$68,812,007

-$159,157,390 QoQ

Shares Held

535,502

-71.7% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

#264

of 3,778 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Employees Provident Fund Board holds $1,255,262,333 across 8 Drug Manufacturers - General names. MRK ranks #4 (5.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	518,259	$621,615,444
2	BMY	Bristol Myers Squibb Co	3,640,333	$209,755,987
3	BIIB	Biogen Inc.	704,196	$152,148,587
4	MRK	Merck & Co., Inc. This page	535,502	$68,812,007
5	JNJ	Johnson & Johnson	266,023	$67,561,861
6	GILD	Gilead Sciences, Inc.	488,657	$61,736,925
7	ABBV	AbbVie Inc.	163,093	$41,040,722
8	AMGN	Amgen Inc	90,000	$32,590,800

All Filings in MRK

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$68,812,007	535,502	-71.7%	Shares	Sole	2026-08-12
2026-03-31	$227,969,397	1,895,165	-21.5%	Shares	Sole	2026-05-12
2025-12-31	$254,206,478	2,415,034	+2.6%	Shares	Sole	2026-03-03
2025-09-30	$197,574,073	2,354,034	+39.4%	Shares	Sole	2026-03-17
2025-06-30	$133,703,931	1,689,034	+11.9%	Shares	Sole	2026-03-17
2025-03-31	$135,540,651	1,510,034	+43.7%	Shares	Sole	2026-03-17
2024-12-31	$104,559,946	1,051,065	+2.4%	Shares	Sole	2026-03-17
2024-09-30	$116,519,941	1,026,065	+2.8%	Shares	Sole	2026-03-17
2024-06-30	$123,553,514	998,009	-14.7%	Shares	Sole	2026-03-18
2024-03-31	$154,406,174	1,170,187	-1.2%	Shares	Sole	2026-03-18
2023-12-31	$129,135,607	1,184,513	+22.3%	Shares	Sole	2026-03-18
2023-09-30	$99,696,985	968,402	+38.8%	Shares	Sole	2026-03-18
2023-06-30	$80,530,565	697,899	+50.6%	Shares	Sole	2026-03-31
2023-03-31	$49,306,339	463,449	+23.6%	Shares	Sole	2026-03-18
2022-12-31	$41,606,250	375,000	-66.3%	Shares	Sole	2026-03-18
2022-09-30	$95,961,190	1,114,273	-47.3%	Shares	Sole	2026-03-18
2022-06-30	$192,789,176	2,114,612	-21.1%	Shares	Sole	2026-03-18
2022-03-31	$220,008,952	2,681,401	+10.1%	Shares	Sole	2026-03-18
2021-12-31	$186,721,710	2,436,348	-7.1%	Shares	Sole	2026-03-18
2021-09-30	$197,038,166	2,623,328	+4.5%	Shares	Sole	2026-03-18
2021-06-30	$195,237,229	2,510,444	+7.8%	Shares	Sole	2026-03-18
2021-03-31	$179,578,630	2,329,466	+30.7%	Shares	Sole	2026-03-18
2020-12-31	$145,789,047	1,782,263	+49.7%	Shares	Sole	2026-03-18
2020-09-30	$98,738,665	1,190,339	+35970.9%	Shares	Sole	2026-03-20
2020-06-30	$255,189	3,300	-99.8%	Shares	Sole	2026-03-31
2020-03-31	$138,689,908	1,802,573	—	Shares	Sole	2026-03-20
No filing history on record for this holder in this stock.